Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-24-001868

Chief Financial Officer sold 50,000 shares at an average $10.35 ($517,508)

  • Chief Financial Officer acquired 75,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Secora Michael · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-16 Exercise or conversion : show line 1 in the form 10b5-1 +37,500 $2.22 $83,250 993,514 D
2024-01-16 Sale : show line 2 in the form 10b5-1 −25,000 $10.45 $261,160 968,514 D
2024-01-17 Exercise or conversion : show line 3 in the form 10b5-1 +37,500 $2.22 $83,250 1,006,014 D
2024-01-17 Sale : show line 4 in the form 10b5-1 −25,000 $10.25 $256,348 981,014 D
Open-market sales · 50,000 sh · avg $10.35 · $517,508

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2024-01-16 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) −37,500 $2.22 2030-03-03 37,500 1,072,635 D
2024-01-17 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −37,500 $2.22 2030-03-03 37,500 1,035,135 D
Loading xslF345X05/doc4.xml…